GGrantIndex
← Leaderboards

Scott M Plafker

University Of Virginia Charlottesville

$8,005,020
Attributed
$8,005,020
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $584.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,005,020 · 11

By mechanism

R01$6,081,545 · 3
P20$1,414,334 · 6
R21$471,625 · 1
F32$37,516 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignMouse ModelIn VivoHomeostasisMediatingKnockout MiceInflammatoryLinkBaseCellsUbiquitinAnimalsTranscription FactorOxidative StressComplexSourceMapsChronicPublishingBinding (Molecular Function)BlindnessAntioxidantsClinical TrialsIncidence

Grant awards (23)

Interrogating the intersection between diet and ocular autoimmunity$541,165
R01 · FY2025 · EY · contact PI
Interrogating the intersection between diet and ocular autoimmunity$567,340
R01 · FY2024 · EY · contact PI
Interrogating the intersection between diet and ocular autoimmunity$562,096
R01 · FY2023 · EY · contact PI
Interrogating the intersection between diet and ocular autoimmunity$580,796
R01 · FY2022 · EY · contact PI
Mitochondrial Dynamics in RPE Homeostasis and Disease$518,575
R01 · FY2021 · EY · contact PI
Mitochondrial Dynamics in RPE Homeostasis and Disease$558,273
R01 · FY2020 · EY · contact PI
Mitochondrial Dynamics in RPE Homeostasis and Disease$584,619
R01 · FY2019 · EY · contact PI
Mitochondrial Dynamics in RPE Homeostasis and Disease$568,798
R01 · FY2018 · EY · contact PI
Treatment strategies for autoimmune demyelinating optic neuritis$214,375
R21 · FY2017 · EY · contact PI
Treatment strategies for autoimmune demyelinating optic neuritis$257,250
R21 · FY2016 · EY · contact PI
Control of redox regulators by the ubiquitin system$325,823
R01 · FY2015 · GM · contact PI
Control of redox regulators by the ubiquitin system$325,823
R01 · FY2014 · GM · contact PI
Control of redox regulators by the ubiquitin system$309,300
R01 · FY2013 · GM · contact PI
Control of redox regulators by the ubiquitin system$325,721
R01 · FY2012 · GM · contact PI
Control of redox regulators by the ubiquitin system$313,216
R01 · FY2011 · GM · contact PI
OKHSC COBRE: THE ROLE OF THE UBIQUITIN SYSTEM IN RETINAL DEGENERATION$164,831
P20 · FY2011 · RR · contact PI
OKHSC COBRE: PROTECTING THE RETINA FROM OXIDATIVE STRESS$214,787
P20 · FY2010 · RR · contact PI
OKHSC COBRE: UBIQUITIN IN HYPERGLYCEMIA-INDUCED MESANGIAL CELL HYPERTROPHY$216,074
P20 · FY2009 · RR · contact PI
OKHSC COBRE: UBIQUITIN IN HYPERGLYCEMIA-INDUCED MESANGIAL CELL HYPERTROPHY$212,651
P20 · FY2008 · RR · contact PI
OKHSC COBRE: UBIQUITIN IN HYPERGLYCEMIA-INDUCED MESANGIAL CELL HYPERTROPHY$282,993
P20 · FY2007 · RR · contact PI
COBRE: OMRF: RECRUITING CORE: ROLE OF UBIQUITIN PATHWAY$137,508
P20 · FY2005 · RR
COBRE: OMRF: RECRUITING CORE: THE ROLE OF UBIQUITIN PATHWAY ENZYMES IN T CELLS$185,490
P20 · FY2004 · RR
KARYOPHERIN X, A NOVEL TRANSPORT RECEPTOR$37,516
F32 · FY2000 · GM